SCIENTIFIC HUB

Follow the evidence.

21.482 articles found

Source record

First-Time Disclosure of CVN424, a Potent and Selective GPR6 Inverse Agonist for the Treatment of Parkinson's Disease: Discovery, Pharmacological Validation, and Identification of a Clinical Candidate.

Sun H, Monenschein H, Schiffer HH, Reichard HA, Kikuchi S, Hopkins M, Macklin TK, Hitchcock S, Adams M, Green J, Brown J, Murphy ST, Kaushal N, Collia DR, Moore S, Ray WJ, English NM, Carlton MBL, Brice NL.

J Med Chem · 2021-04-16

DOI: 10.1021/acs.jmedchem.0c02081PMID: 33861086

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.
Source record

Causal Connection Between Serum Levodopa Metabolic Profile and Medication in Parkinson’s Disease

Chukyo A, Fujimaki M, Kaga N, Taka H, Li Y, Ueno S, Takeshige-Amano H, Funayama M, Ishimaru T, Miyamoto K, Teranishi H, Hatano T, Ishikawa K, Oji Y, Mori A, Tsunemi T, Ishiguro Y, Daida K, Imamichi Y, Sasazawa Y, Kataura T, Kitagawa M, Nishikawa N, Imoto M, Ueno T, Komori O, Miura Y, Akamatsu W, Hattori N, Saiki S.

· 2021-04-13

DOI: 10.21203/rs.3.rs-388258/v1

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Records come from scientific sources. Bibliographic counts do not represent completed translations or editorial approvals.

Filters

Filters

Clear
Publication year
Research area
Author
Journal
Publication type
Source & language
Open accessAccess does not establish reuse rights.